JAMA Clinical Reviews Localized and Metastatic Prostate Cancer
12 snips
Mar 10, 2025 R. Bruce Montgomery, a Professor at the University of Washington and an expert in prostate cancer, joins Karen Lasser to delve into crucial aspects of prostate cancer management. They discuss the complexities of the disease's epidemiology, particularly its prevalence among older and Black men. Updated screening recommendations emphasize shared decision-making. Montgomery highlights the importance of risk stratification in treatment, challenges in managing metastatic cases, and advances in therapies that enhance patient survival and quality of life.
AI Snips
Chapters
Transcript
Episode notes
Prostate Cancer Prevalence and Lethality
- Prostate cancer is the most common solid tumor in the US and worldwide.
- Not everyone diagnosed with it is at risk of dying from it, even without therapy.
Prostate Cancer Screening
- Current screening recommendations involve shared decision-making due to limited impact on overall survival.
- Screening is generally recommended for men aged 50-69, with earlier consideration for Black men.
Clinical Presentation of Prostate Cancer
- Most men with prostate cancer don't experience symptoms initially.
- Urinary symptoms can occur with significant tumor volume, but these are not specific to prostate cancer.